돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 359884생성일: 2026년 10월 25일

Indomethacin → N-(2-{[1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl]acetoxy}ethyl)-3-pyridinecarboxamide

https://huagongshe.com/reaction/359884

반응식

참여 물질

역할이름HCID투입량
반응물IndomethacinHCID 3715—
반응물AcetonitrileHCID 6342—
반응물DicyclohexylcarbodiimideHCID 10868—
반응물N-(2-hydroxyethyl)nicotinamideHCID 72663—
용매Diethyl EtherHCID 3283—
생성물N-(2-{[1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl]acetoxy}ethyl)-3-pyridinecarboxamideHCID 1568001665.2%

반응 조건

온도0 °C

반응 단계

A reaction of indomethacin (1.79 g, 5.00 mmol) and the product of Example 91 (0.830 g, 5.00 mmol) was carried out, using dicyclohexylcarbodiimide (1.10 g, 5.50 mmol) as the coupling agent and acetonitrile as the solvent. The first two reactants were dissolved completely and the solution was then cooled to 0° C. The dicyclohexylcarbodiimide was added and the mixture was stirred overnight. The reaction was allowed to continue for 48 hours. The precipitate (1.2 g) was removed by vacuum filtration. The solvent was removed from the filtrate under reduced pressure leaving an oily residue. The product was solidified by stirring with anhydrous ether. It was filtered, air-dried and recrystallized from ethanol/ether. The final product was vacuum filtered, washed with ether, and air dried. The product weighed 1.65 g, giving a 65.2% yield; mp 123°-125° C.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05002935
출처 데이터셋uspto-grants-1991_03
ORD IDord-2464e0303d2d46ea8860188b13d109a6
출처 메모uspto-grants-1991_03